ImmuCell Corporation Common Stock — Institutional Ownership
Which tracked institutions hold ICCC, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
6
Funds holding
$2738845
Total value held
Buying
4 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $2350796 | 233910 | +12194 | +5.50% |
| 2 | Blackrock, Inc. | $229744 | 22860 | +4674 | +25.70% |
| 3 | Northern Trust Corp | $147946 | 14721 | -26897 | -64.63% |
| 4 | Ubs Group Ag | $10050 | 1000 | +1000 | NEW BUY |
| 5 | Barclays Plc | $302 | 30 | +30 | NEW BUY |
| 6 | Wells Fargo & Company/Mn | $7 | 1 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.